Argatroban is a synthetic direct thrombin inhibitor that serves as a vital anticoagulant for the treatment and prophylaxis of thrombosis in patients with heparin-induced thrombocytopenia and those undergoing… Read more







![Chemical structure of (2R,4R)-1-[(2S)-2-[(tert-Butyloxycarbonyl)amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid Benzyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F367952-82-7-2R4R-1-2S-2-tert-Butyloxycarbonylamino-5-iminonitroaminomethylamino-1-oxopentyl-4-methyl-2-piperidinecarboxylic-Acid-Benzyl-Ester.png&w=3840&q=75)









![Chemical structure of (2R,4R)1-[(2S)2-Amino-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid Ethyl Ester Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F74874-08-1-2R4R1-2S2-Amino-5-iminonitroaminomethylamino-1-oxopentyl-4-methyl-2-piperidinecarboxylic-Acid-Ethyl-Ester-Hydrochloride.png&w=3840&q=75)





![Chemical structure of (2S,4S)-1-[(2S)-2-[(tert-Butyloxycarbonyl)amino]-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid Benzyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S4S-1-2S-2-tert-Butyloxycarbonylamino-5-iminonitroaminomethylamino-1-oxopentyl-4-methyl-2-piperidinecarboxylic-Acid-Benzyl-Ester.png&w=3840&q=75)
![Chemical structure of (2S,4S)-1-[(2S)-2-Amino-5-[[imino(nitroamino)methyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic Acid Benzyl Ester Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S4S-1-2S-2-Amino-5-iminonitroaminomethylamino-1-oxopentyl-4-methyl-2-piperidinecarboxylic-Acid-Benzyl-Ester-Hydrochloride.png&w=3840&q=75)

























Argatroban is a synthetic direct thrombin inhibitor that serves as a vital anticoagulant for the treatment and prophylaxis of thrombosis in patients with heparin-induced thrombocytopenia and those undergoing percutaneous coronary intervention. To ensure pharmaceutical consistency and regulatory compliance, laboratories rely on a comprehensive range of related compounds, including synthetic intermediates, degradation products, and metabolites. These substances are essential as reference standards during analytical testing to perform precise impurity profiling and rigorous method validation. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification and supports reliable quality control processes throughout the drug development lifecycle. By utilizing these characterized reference materials, analytical chemists can effectively identify, monitor, and control potential impurities, thereby maintaining the high safety and efficacy standards required for this critical therapeutic agent.